Octozi

What Octozi does

Octozi helps the pharma industry accelerate drug approvals with AI agents. Over $100 billion is spent on clinical development and thousands of hours of manual work goes into creating documentation, cleaning, and analyzing the data required for regulatory submission. Our AI-augmented platform automates processes involved in data cleaning and review, decreasing the time needed for database lock while enhancing data quality. Octozi helps sponsors automate clinical data workflows across data cleaning, data review, reconciliation, reporting, and clinical operations using artificial intelligence.

Products

• Octozi Clinical Intelligence PlatformA platform with five modules built on a unified platform and clinical intelligence engine, designed to accelerate clinical development using AI agents.
• Octozi — continuous review engineA component of the Octozi platform for continuous review.

Key capabilities

• AI agents to accelerate clinical development
• Automates clinical data workflows
• Automates processes in data cleaning and review
• Decreases time needed for database lock
• Enhances data quality
• One workspace for the whole study team
• Five modules built on a unified platform and clinical intelligence engine
• No training on your data
• Private data stays private (siloed environments)
• Full data visibility
• Modern & secure data practices (zero-trust, least privilege, strong authentication)
• Encrypted everywhere
• Audited & tested by third-party specialists

Use cases

• Accelerate drug approvals
• Automate clinical data workflows
• Data cleaning
• Data review
• Reconciliation
• Reporting
• Clinical operations
• Automating documentation creation
• Automating data cleaning for regulatory submission
• Automating data analysis for regulatory submission
• AI Medical Data Review
• AI Safety Review and Reconciliation

AI approach

Octozi uses AI agents to automate clinical data workflows across data cleaning, data review, reconciliation, reporting, and clinical operations. Their platform is built on a clinical intelligence engine and explicitly states that it does not use private customer data to train or update its models, suggesting proprietary models.

Tech named: AI agents, clinical intelligence engine

Industries served

• Pharma
• Life sciences

What it says sets it apart

• 85% reduction in data errors
• Median throughput improvement
• SOC 2 Type II compliant
• GDPR compliant
• 21 CFR Part 11 compliant
• GxP validated
• Never uses private data to train or update models
• Data stored in siloed environments, isolated from other customer data
• Control data access and usage with full insight into operations
• Employs zero-trust, least privilege, and strong authentication
• User data securely managed across storage and networks
• Undergoes regular audits and tests for vulnerabilities by third-party specialists

Funding rounds we track

From the AI funding tracker — rounds as reported by the linked publications.